Literature DB >> 11751672

Angiotensin converting enzyme inhibition and hospitalisation rates for heart failure in the Netherlands, 1980 to 1999: the end of an epidemic?

A Mosterd, J B Reitsma, D E Grobbee.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11751672      PMCID: PMC1766961          DOI: 10.1136/heart.87.1.75

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  8 in total

1.  Have we jugulated the epidemic of heart failure? One swallow does not make a summer...

Authors:  F Zannad
Journal:  Eur Heart J       Date:  2001-02       Impact factor: 29.983

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.

Authors:  M D Flather; S Yusuf; L Køber; M Pfeffer; A Hall; G Murray; C Torp-Pedersen; S Ball; J Pogue; L Moyé; E Braunwald
Journal:  Lancet       Date:  2000-05-06       Impact factor: 79.321

Review 4.  The epidemiology of heart failure.

Authors:  M R Cowie; A Mosterd; D A Wood; J W Deckers; P A Poole-Wilson; G C Sutton; D E Grobbee
Journal:  Eur Heart J       Date:  1997-02       Impact factor: 29.983

5.  Preventable causative factors leading to hospital admission with decompensated heart failure.

Authors:  A Michalsen; G König; W Thimme
Journal:  Heart       Date:  1998-11       Impact factor: 5.994

6.  Trends in hospitalization for heart failure in Scotland, 1990-1996. An epidemic that has reached its peak?

Authors:  S Stewart; K MacIntyre; M M MacLeod; A E Bailey; S Capewell; J J McMurray
Journal:  Eur Heart J       Date:  2001-02       Impact factor: 29.983

7.  Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.

Authors:  B Neal; S MacMahon; N Chapman
Journal:  Lancet       Date:  2000-12-09       Impact factor: 79.321

8.  Increase in hospital admission rates for heart failure in The Netherlands, 1980-1993.

Authors:  J B Reitsma; A Mosterd; A J de Craen; R W Koster; F J van Capelle; D E Grobbee; J G Tijssen
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

  8 in total
  13 in total

Review 1.  Global perspectives in hospitalized heart failure: regional and ethnic variation in patient characteristics, management, and outcomes.

Authors:  Andrew P Ambrosy; Mihai Gheorghiade; Ovidiu Chioncel; Robert J Mentz; Javed Butler
Journal:  Curr Heart Fail Rep       Date:  2014-12

Review 2.  Understanding the epidemic of heart failure: past, present, and future.

Authors:  Shannon M Dunlay; Véronique L Roger
Journal:  Curr Heart Fail Rep       Date:  2014-12

3.  Results of a heart failure outpatient clinic in a non-university hospital with a two-year follow-up.

Authors:  C M H B Lucas; G Cleuren; C van Rees
Journal:  Neth Heart J       Date:  2003-04       Impact factor: 2.380

Review 4.  Specialist nurse management programmes: economic benefits in the management of heart failure.

Authors:  Simon Stewart; John D Horowitz
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

5.  National trends in heart failure hospital stay rates, 2001 to 2009.

Authors:  Jersey Chen; Kumar Dharmarajan; Yongfei Wang; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2013-03-12       Impact factor: 24.094

6.  Prognosis for patients newly admitted to hospital with heart failure: survival trends in 12 220 index admissions in Leicestershire 1993-2001.

Authors:  H M Blackledge; J Tomlinson; I B Squire
Journal:  Heart       Date:  2003-06       Impact factor: 5.994

Review 7.  Nuclear cardiology and heart failure.

Authors:  Raffaele Giubbini; Elisa Milan; Francesco Bertagna; Fernando Mut; Marco Metra; Carlo Rodella; Maurizio Dondi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12       Impact factor: 9.236

Review 8.  Benefits of optimising drug treatment in home-dwelling elderly patients with coronary artery disease.

Authors:  Timo Strandberg; Kaisu Pitkala; Reijo Tilvis
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 9.  The causes, consequences, and treatment of left or right heart failure.

Authors:  Pablo Pazos-López; Jesús Peteiro-Vázquez; Ana Carcía-Campos; Lourdes García-Bueno; Juan Pablo Abugattas de Torres; Alfonso Castro-Beiras
Journal:  Vasc Health Risk Manag       Date:  2011-04-04

10.  The Ecology of Medical Care in Norway: Wide Use of General Practitioners may not Necessarily Keep Patients out of Hospitals.

Authors:  Anne Helen Hansen; Peder A Halvorsen; Olav Helge Forde
Journal:  J Public Health Res       Date:  2012-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.